Daniel Ocarroll, DPM
Sports Medicine · Glen Ellyn, ILNPI 1437142858
Payments from drug & device makers
Across 188 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$2K
- Smith+Nephew$210
- Stryker$178
- Integra Lifesciences Corporation$169
- Pacira Pharmaceuticals Incorporated$100
- Johnson & Johnson$91
- plus $495 from 13 others
What the payments were for
- Food & beverage$3,598100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 146 | $2,355 |
| Smith+Nephew | 4 | $210 |
| Stryker | 3 | $178 |
| Integra Lifesciences Corporation | 3 | $169 |
| Pacira Pharmaceuticals Incorporated | 2 | $100 |
| Johnson & Johnson | 3 | $91 |
| Paragon 28, Inc. | 2 | $90 |
| Sebela Pharmaceuticals Inc. | 4 | $70 |
| Flower Orthopedics Coporation | 1 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Fusion Orthopedics USA, LLC | 2 | $47 |
| Fidia Pharma USA Inc. | 7 | $39 |
| Treace Medical Concepts, Inc. | 1 | $35 |
| Vertex | 2 | $33 |
| Linvatec Corporation | 1 | $17 |
| Axogen | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $15 |
| DJO, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$437
- INTEGRA$387
- Versajet$160
- INTEGRA DERMAL REGENERATION TEMPLATE$129
- PRIMATRIX$129
- ORTHOLOC 3DI$120
How this compares
$3,598 in reported general payments places this provider in the 60th percentile of 233 sports medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 190 | $4,238 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 40 | $1,993 |
| Celecoxib | 30 | $1,539 |
| Ketoconazole | 47 | $1,470 |
| Betamethasone Valerate | 45 | $1,307 |
| SsdSilver Sulfadiazine | 88 | $887 |
| Bumetanide | 38 | $760 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $731 |
| Fluconazole | 43 | $526 |
| Clindamycin Phosphate | 14 | $474 |
| Silver Sulfadiazine | 56 | $376 |
| Hydromorphone Hcl | 16 | $317 |
| Mupirocin | 25 | $186 |
| Cefadroxil | 36 | $181 |
| Meloxicam | 46 | $172 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Glen Ellyn
- Benjamin DombDes Plaines$18.1M
- Gregory NicholsonChicago$6.7M
- Grant GarriguesChicago$3.1M
- Brian ColeChicago$3.1M
- Brian ForsytheChicago$2M
- Nikhil VermaChicago$1M
- Shane NhoChicago$668K
- Adam YankeChicago$388K
- Jason KohSkokie$227K
- Jourdan CancienneJoliet$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.